A new study on the benefits of marijuana by a neurologist Orrin Devinsky. The researchers found a finding that there is a component of marijuana that can cure epilepsy. Components used marijuana as a cure for epilepsy is Cannabidiol.
Orrin Devinsky very confident that Cannabidiol can reduce severe seizures in patients with epilepsy. Because he has conducted experiments on some epilepsy patients for 3 months. By taking extracts from Cannabidiol given to the patient.
Cannabidiol were able to reduce the psychoactive effects of THC. Especially euphoria capable of inducing chemicals in marijuana. However, Cannabidiol also have antioxidant and anti-inflammatory effects. Very useful for people with multiple sclerosis and Crohn’s disease.
eDocMMJ is here to assist you in becoming a legal Medical Marijuana Patient. Medical Marijuana Doctors in Florida can help you with Medical Marijuana Card Registration, getting a Medical Marijuana Doctor Recommendation, and completing the Marijuana Registry Applications all right over the phone and/or video chat.
Medical Marijuana in Florida have satellite locations all over the country to meet your needs. Their primary goal is provide their patients with a safe and effective way to seek cannabis therapy for their medical conditions.
The new study of marijuana involving 137 patients with epilepsy. The average age was 11 years. Initially the patients with epilepsy had refused to be treated. However, the medical team managed to convince the epilepsy patients to cure their disease. Each patient was given Cannabidiol in liquid form. As a result, seizures declined in the 12 weeks of treatment.
However, Cannabidiol still have side effects. The patients who received the treatment had diarrhea, drowsiness, fatigue and loss of appetite. Until finally 12 patients out of 137 people stop using Cannabidiol. They can not stand the side effects are acceptable due to the extract of marijuana.
Devinsky said that Cannabidiol remains to be tested again against placebo patients with epilepsy. The results of the trial will be presented at a meeting of the American Academy of Neurology. The meeting will be held on April 12, 2015. It will be delivered directly by Orrin Devinsky.